Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS fell 500.0%, free cash flow fell 60.6% and total debt rose 4.92%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

14.64 0.13 −0.88%
Market cap
$1.9B
P/E
0.0×
Fwd P/E
−94.9×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 4 4 5

+8 more TTM periods

ROE
(2.83%) (2.43%) (2.46%) (5.48%)
ROA
(1.11%) (0.95%) (0.97%) (2.21%)
ROIC
3.61% 3.71% 3.69% 3.91%
Return on Tangible Assets
(5.30%) (4.65%) (4.61%) (10.20%)
Average Days of Receivables
66.86 65.87 66.43 64.31
Free Cash Flow per Share
1.49 1.95 1.90 1.87
Free Cash Flow
191.50 249.70 242.10 238.10
Other line items

Show all line items

Columns are period end dates